샘플 요청 목록

 카트 문의
시장보고서
상품코드
1485862

나노테크놀러지 약물전달 시장 : 기술 유형별, 투여 형태별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Nanotechnology Drug Delivery Market, By Technology Type, By Mode of Administration, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

나노테크놀러지 약물전달 시장 규모는 2023년 891억 9,843만 달러로 2024년부터 2032년까지 연평균 9.81% 성장할 것으로 예상됩니다.

나노테크놀러지 약물전달 시장 - 시장 역학

만성질환률의 증가로 첨단 나노테크놀러지 약물전달 솔루션에 대한 수요가 증가

세계 만성질환의 증가로 인해 첨단 나노테크놀러지 약물전달 솔루션에 대한 수요가 증가하고 있습니다. 예를 들어, 세계보건기구(WHO)에 따르면 비감염성 질환(NCDs)은 전 세계 사망원인의 약 71%를 차지하며, 심혈관 질환, 암, 호흡기 질환, 당뇨병이 주요 원인으로 꼽힙니다. 이러한 건강 문제에 대응하기 위해 미국 국립보건원(NIH)과 같은 기관은 부작용을 최소화하면서 만성질환을 효과적으로 치료할 수 있는 표적 약물전달 시스템을 개발하기 위해 나노의학 연구에 대한 투자를 늘리고 있습니다. 또한, 화이자와 노바티스와 같은 제약사들은 만성질환 치료의 치료 성과와 환자 순응도를 높이기 위해 나노테크놀러지 기반의 약물전달 플랫폼을 적극적으로 모색하고 있습니다. 이러한 혁신적인 약물전달 솔루션에 대한 관심은 나노기술의 진보를 통해 만성질환의 부담을 해결하는 것이 시급하다는 것을 입증하고 있습니다.

나노테크놀러지 약물전달 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 9.81%의 CAGR로 성장할 것으로 예상됩니다.

기술 유형 세분화에 따라 나노입자가 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

투여 형태별로는 2023년 정맥투여가 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년에 가장 큰 수익을 창출할 주요 시장입니다.

나노테크놀러지 약물전달 시장 - 세분화 분석:

나노테크놀러지 약물전달 세계 시장은 기술 유형, 투여 형태, 용도 및 지역에 따라 세분화됩니다.

시장은 기술 유형에 따라 나노결정, 나노입자, 리포좀, 미셀, 덴드리머 등 5가지 범주로 나뉩니다. 나노입자는 다재다능함과 표적 약물전달의 효과로 인해 나노기술 약물전달 시장에서 지배적인 기술 유형으로 부상하고 있습니다. 크기와 표면 특성을 정밀하게 제어할 수 있는 나노입자는 안정성, 생체적합성, 치료용 페이로드 용량을 향상시켜 시장 보급을 촉진하고 있습니다.

시장은 투여 형태에 따라 경구, 정맥, 경피, 흡입 등 4가지 범주로 나뉩니다. 정맥 투여는 전신 순환에 직접 접근할 수 있고 빠른 작용 발현으로 인해 나노테크놀러지 기반 약물전달 시장에서 가장 중요한 투여 형태입니다. 이 형태는 약물전달을 정밀하게 제어할 수 있어 즉각적인 치료 개입이 필요한 중증 질환에 적합합니다.

나노테크놀러지 약물전달 시장 - 지리적 인사이트

북미는 탄탄한 연구 인프라와 헬스케어 및 나노기술에 대한 높은 투자로 시장을 선도하고 있으며, Amgen Inc. 및 Johnson & Johnson과 같은 기업들이 혁신적인 약물전달 시스템을 개발하고 있습니다. 유럽에서는 스위스, 영국과 같은 국가들이 상당한 진전을 보이고 있으며, Roche Holding AG와 AstraZeneca PLC와 같은 기업들이 나노테크놀러지 기반 솔루션에 투자하고 있습니다. 한편, 인도와 일본을 중심으로 한 아시아태평양은 의료비 증가와 만성 질환의 확산으로 인해 빠르게 성장하고 있으며, Sun Pharmaceutical Industries Ltd.와 다케다제약과 같은 지역 기업들은 나노기술을 활용하여 맞춤형 약물전달 시스템을 개발하고 있습니다.

나노테크놀러지 약물전달 시장 - 경쟁 상황:

Amgen Inc., Johnson & Johnson, Roche Holding AG, AstraZeneca PLC와 같은 주요 기업들이 나노테크놀러지 기반의 새로운 약물전달 시스템을 혁신하기 위해 연구개발에 많은 투자를 하고 있습니다. 이들 기업은 치료 효과와 환자 순응도를 개선하기 위해 표적화되고 효율적인 약물전달 플랫폼 개발에 집중하고 있습니다. 또한 전략적 제휴, 파트너십 및 인수는 제품 포트폴리오를 강화하고 지리적 입지를 확대하기 위해 시장 기업이 채택하는 일반적인 전략입니다. 예를 들어, 2022년 세계 제약회사 화이자(Pfizer)는 나노 의약품 전문 생명공학 기업 BIND Therapeutics와의 제휴를 발표했습니다. 이 제휴는 나노입자를 이용한 표적 약물전달 플랫폼인 BIND의 Accurin 기술을 활용하여 화이자의 암 치료제 전달을 강화하는 것을 목표로 하고 있습니다. 이번 제휴를 통해 효능을 높이고 부작용을 줄인 새로운 암 치료제의 개발을 촉진할 수 있게 됐습니다. 신생기업과 스타트업들도 파괴적 기술이나 틈새 약물전달 솔루션을 도입하여 시장 경쟁에 기여하고 있습니다.

목차

제1장 나노테크놀러지 약물전달 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 나노테크놀러지 약물전달의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 나노테크놀러지 약물전달 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 나노테크놀러지 약물전달 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 나노테크놀러지 약물전달 시장 상황

  • 나노테크놀러지 약물전달 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 나노테크놀러지 약물전달 시장 : 기술 유형별

  • 개요
    • 기술 유형별 부문 점유율 분석
    • 나노결정
    • 나노입자
    • 리포솜
    • 미셀
    • 덴드리머
    • 기타

제8장 나노테크놀러지 약물전달 시장 : 투여 형태별

  • 개요
    • 투여 형태별 부문 점유율 분석
    • 경구
    • 정맥내
    • 경피
    • 흡입
    • 기타

제9장 나노테크놀러지 약물전달 시장 : 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 종양
    • 심혈관질환
    • 신경
    • 항염증/면역
    • 항감염
    • 기타

제10장 나노테크놀러지 약물전달 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 나노테크놀러지 약물전달 업계

  • 경쟁 대시보드
  • 기업 개요
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Celator Pharmaceuticals Inc
    • Celgene Corporation
    • Celsion Corporation
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck &Co., Inc.
    • Nanobiotix SA
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Others

제12장 애널리스트의 전방위 전망

ksm 24.06.11

REPORT HIGHLIGHT

Nanotechnology Drug Delivery Market size was valued at USD 89,198.43 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

The Nanotechnology Drug Delivery Market, leveraging nanoscale materials for targeted and efficient drug delivery, is poised for significant growth. The potential for enhanced drug efficacy and reduced side effects, increasing investments in nanomedicine research, and the rising prevalence of chronic diseases demanding novel therapeutic solutions drive market growth. However, market growth is restrained by challenges such as regulatory complexities, concerns regarding toxicity and biocompatibility, and high research and development costs. Opportunities lie in the development of novel nanocarriers for gene therapy, personalized medicine, and the utilization of nanotechnology for overcoming biological barriers, thereby expanding the scope of drug delivery applications.

Nanotechnology Drug Delivery Market- Market Dynamics

Rising Chronic Disease Rates Propel Demand for Advanced Nanotechnology Drug Delivery Solutions

The escalating rates of chronic diseases worldwide are driving the demand for advanced nanotechnology drug delivery solutions. For instance, according to the World Health Organization (WHO), non-communicable diseases (NCDs) account for approximately 71% of all deaths globally, with cardiovascular diseases, cancer, respiratory diseases, and diabetes being the leading causes. In response to this health challenge, organizations like the National Institutes of Health (NIH) in the United States are increasingly investing in nanomedicine research to develop targeted drug delivery systems that can effectively treat chronic conditions while minimizing side effects. Additionally, pharmaceutical companies such as Pfizer and Novartis are actively exploring nanotechnology-based drug delivery platforms to enhance therapeutic outcomes and patient compliance in the treatment of chronic diseases. This growing emphasis on innovative drug delivery solutions underscores the urgent need to address the burden of chronic illnesses through nanotechnology advancements.

Nanotechnology Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Technology Type segmentation, Nanoparticles were predicted to show maximum market share in the year 2023

Based on Mode of Administration segmentation, Intravenous was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanotechnology Drug Delivery Market- Segmentation Analysis:

The Global Nanotechnology Drug Delivery Market is segmented on the basis of Technology Type, Mode of Administration, Application, and Region.

The market is divided into five categories based on Technology Type: Nanocrystals, Nanoparticles, Liposomes, Micelles, and Dendrimers. Nanoparticles have emerged as the dominant technology type in the Nanotechnology Drug Delivery Market due to their versatility and effectiveness in targeted drug delivery. With precise control over size and surface properties, nanoparticles offer enhanced stability, biocompatibility, and therapeutic payload capacity, driving their higher market adoption.

The market is divided into four categories based on the Mode of Administration: Oral, Intravenous, Transdermal, and Inhalation. Intravenous administration stands out as the primary mode in the Nanotechnology Drug Delivery Market, owing to its direct access to systemic circulation and rapid onset of action. This mode offers precise control over drug delivery, making it suitable for critical medical conditions requiring immediate therapeutic intervention.

Nanotechnology Drug Delivery Market- Geographical Insights

North America leads the market due to robust research infrastructure and high investments in healthcare and nanotechnology, with players like Amgen Inc. and Johnson & Johnson pioneering innovative drug delivery systems. In Europe, countries like Switzerland and the United Kingdom are witnessing significant advancements, with companies such as Roche Holding AG and AstraZeneca PLC investing in nanotechnology-based solutions. Meanwhile, the Asia Pacific region, led by India and Japan, is experiencing rapid growth fueled by increasing healthcare expenditure and rising chronic disease prevalence. Regional players like Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited are leveraging nanotechnology to develop tailored drug delivery systems.

Nanotechnology Drug Delivery Market- Competitive Landscape:

Leading companies such as Amgen Inc., Johnson & amp; Johnson, Roche Holding AG, and AstraZeneca PLC are at the forefront, investing significantly in research and development to innovate novel nanotechnology-based drug delivery systems. These companies focus on developing targeted and efficient drug delivery platforms to improve therapeutic outcomes and patient compliance. Additionally, strategic collaborations, partnerships, and acquisitions are common strategies employed by market players to strengthen their product portfolios and expand their geographic presence. For instance, in 2022, Pfizer, a global pharmaceutical company, announced a collaboration with BIND Therapeutics, a biotechnology company specializing in nanomedicine. The collaboration aimed to utilize BIND's Accurin technology, a targeted drug delivery platform utilizing nanoparticles, to enhance the delivery of Pfizer's oncology therapeutics. This partnership facilitated the development of novel cancer treatments with improved efficacy and reduced side effects. Emerging players and startups are also contributing to market competitiveness by introducing disruptive technologies and niche drug delivery solutions.

Recent Developments:

In September 2021, Nanovis announced the launch of the first and only bioceramic nanotube-enhanced pedicle screw system, nano fortifix(R), showcasing a pioneering nanotechnology-enhanced pedicle screw system with label claims to enhance bone growth

In July 2020, Curadigm Announces EUR 1 million in funding from BPI France's Deep Tech Program to Support the Development of the Nanoprimer Platform, highlighting a substantial investment in their Nanoprimer technology to enhance therapeutic bioavailability and efficacy across various drug classes

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bristol-Myers Squibb Company

Celator Pharmaceuticals Inc

Celgene Corporation

Celsion Corporation

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co., Inc.

Nanobiotix S.A.

Novartis International AG

Pfizer Inc.

Roche Holding AG

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Dendrimers
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Transdermal
  • Inhalation
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanotechnology Drug Delivery Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanotechnology Drug Delivery Market Snippet by Technology Type
    • 2.1.2.Nanotechnology Drug Delivery Market Snippet by Mode of Administration
    • 2.1.3.Nanotechnology Drug Delivery Market Snippet by Application
    • 2.1.4.Nanotechnology Drug Delivery Market Snippet by Country
    • 2.1.5.Nanotechnology Drug Delivery Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanotechnology Drug Delivery Key Market Trends

  • 3.1.Nanotechnology Drug Delivery Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanotechnology Drug Delivery Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanotechnology Drug Delivery Market Opportunities
  • 3.4.Nanotechnology Drug Delivery Market Future Trends

4.Nanotechnology Drug Delivery Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanotechnology Drug Delivery Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanotechnology Drug Delivery Market Landscape

  • 6.1.Nanotechnology Drug Delivery Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanotechnology Drug Delivery Market - By Technology Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 7.1.2.Nanocrystals
    • 7.1.3.Nanoparticles
    • 7.1.4.Liposomes
    • 7.1.5.Micelles
    • 7.1.6.Dendrimers
    • 7.1.7.Others

8.Nanotechnology Drug Delivery Market - By Mode of Administration

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 8.1.2.Oral
    • 8.1.3.Intravenous
    • 8.1.4.Transdermal
    • 8.1.5.Inhalation
    • 8.1.6.Others

9.Nanotechnology Drug Delivery Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Cardiovascular Diseases
    • 9.1.4.Neurology
    • 9.1.5.Anti-inflammatory/Immunology
    • 9.1.6.Anti-infective
    • 9.1.7.Others

10.Nanotechnology Drug Delivery Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Nanotechnology Drug Delivery Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Nanotechnology Drug Delivery Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Nanotechnology Drug Delivery Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Nanotechnology Drug Delivery Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Nanotechnology Drug Delivery Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Nanotechnology Drug Delivery Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.AbbVie Inc.
    • 11.2.2.Amgen Inc.
    • 11.2.3.AstraZeneca plc
    • 11.2.4.Bristol-Myers Squibb Company
    • 11.2.5.Celator Pharmaceuticals Inc
    • 11.2.6.Celgene Corporation
    • 11.2.7.Celsion Corporation
    • 11.2.8.GlaxoSmithKline plc
    • 11.2.9.Johnson & Johnson
    • 11.2.10.Merck & Co., Inc.
    • 11.2.11.Nanobiotix S.A.
    • 11.2.12.Novartis International AG
    • 11.2.13.Pfizer Inc.
    • 11.2.14.Roche Holding AG
    • 11.2.15.Sanofi S.A.
    • 11.2.16.Teva Pharmaceutical Industries Ltd.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제